Benztropine mesylate

• CAT Number: A001146
• CAS Number: 132-17-2
• Molecular Formula: C21H25NO • CH3SO3H
• Molecular Weight: 403.54
• Purity: ≥95%
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO > 10 mM
• Storage: store at -20℃
• IUPAC Name: (1R,5S)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane;methanesulfonic acid
• InChI: InChI=1S/C21H25NO.CH4O3S/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-5(2,3)4/h2-11,18-21H,12-15H2,1H3;1H3,(H,2,3,4)/t18-,19+,20?
• InChIKey: CPFJLLXFNPCTDW-IIPFOPBBSA-N
• SMILES: CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O

Benztropine mesylate（Cat No.:A001146）is a medication primarily used to treat symptoms of Parkinson’s disease and drug-induced extrapyramidal symptoms, such as tremors and rigidity. It is an anticholinergic and antihistaminic agent that works by blocking acetylcholine receptors, helping to restore the balance between acetylcholine and dopamine in the brain, which is often disrupted in Parkinson’s disease. By inhibiting muscarinic receptors, benztropine reduces the symptoms of movement disorders. It is typically prescribed as an adjunct to dopaminergic therapy. Benztropine mesylate can also be used to manage side effects caused by antipsychotic medications.